Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review

DSW Ting, GCM Cheung… - Clinical & experimental …, 2016 - Wiley Online Library
Diabetes retinopathy (DR) is a leading cause of vision loss in middle‐aged and elderly
people globally. Early detection and prompt treatment allow prevention of diabetes‐related …

Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review

R Li, P Zhang, LE Barker, FM Chowdhury… - Diabetes …, 2010 - Am Diabetes Assoc
OBJECTIVE To synthesize the cost-effectiveness (CE) of interventions to prevent and control
diabetes, its complications, and comorbidities. RESEARCH DESIGN AND METHODS We …

Screening for diabetes in adults

JM Ekoe, R Goldenberg, P Katz… - Canadian journal of …, 2018 - Elsevier
Screening for diabetes implies testing for diabetes in individuals without symptoms who are
unaware of their condition. Screening for diabetes will also detect individuals at increased …

Screening for type 2 diabetes: literature review and economic modelling

N Waugh, G Scotland, P McNamee, M Gillett… - HEALTH …, 2007 - emerald.com
Background The National Screening Committee (NSC) is responsible for providing advice
on screening policy to all parts of the UK. A review of policy on screening for type 2 diabetes …

Screening for type 2 diabetes mellitus

N Peer, Y Balakrishna, S Durao - Cochrane Database of …, 2020 - cochranelibrary.com
Background Diabetes mellitus, a metabolic disorder characterised by hyperglycaemia and
associated with a heavy burden of microvascular and macrovascular complications …

[PDF][PDF] A review and critique of modelling in prioritising and designing screening programmes

J Karnon, E Goyder, P Tappenden… - HEALTH …, 2007 - researchgate.net
Objectives The objective of this report was to undertake a structured review and critical
appraisal of methods for the model-based cost–utility analysis of screening programmes. It …

[PDF][PDF] Screening for type 1 and type 2 diabetes

JM Ekoé, Z Punthakee, T Ransom… - Canadian journal of …, 2013 - thehub.utoronto.ca
Testing with a 2-hour plasma glucose (2hPG) in a 75 g oral glucose tolerance test (OGTT)
should be undertaken in individuals with an FPG of 6.1 e6. 9 mmol/L and/or an A1C of 6.0 …

Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic …

BS Bagepally, YK Gurav, T Anothaisintawee… - BMJ Open Diabetes …, 2020 - drc.bmj.com
Objectives To conduct a systematic review and meta-analysis and to pool the incremental
net benefits (INBs) of glucagon-like peptide 1 (GLP1) compared with other therapies in type …

[HTML][HTML] Cost utility of sodium-glucose cotransporter 2 inhibitors in the treatment of metformin monotherapy failed type 2 diabetes patients: a systematic review and …

BS Bagepally, YK Gurav, T Anothaisintawee… - Value in Health, 2019 - Elsevier
Objectives Type 2 diabetes mellitus (T2DM) and associated ailments are leading economic
burdens to society. Sodium glucose cotransporter-2 (SGLT2) inhibitors are recent …

A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment

JE Tarride, R Hopkins, G Blackhouse, JM Bowen… - …, 2010 - Springer
Diabetes mellitus is a major healthcare concern from both a treatment and a funding
perspective. Although decision makers frequently rely on models to evaluate the long-term …